Skip to Main Content

Paper Details

The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera.
medRxiv
87
2021
Author NameAffiliation
Raveen RathnasingheIcahn School of Medicine at Mount Sinai New York
Raveen RathnasingheIcahn School of Medicine at Mount Sinai
Raveen RathnasingheGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
Carles Mart??nez-RomeroIcahn School of Medicine at Mount Sinai New York
Carles Mart??nez-RomeroGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
Lubbertus C F MulderIcahn School of Medicine at Mount Sinai New York
Lubbertus C F MulderGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
Soner YildizIcahn School of Medicine at Mount Sinai New York
Soner YildizGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
Ignacio MenaIcahn School of Medicine at Mount Sinai New York
Ignacio MenaGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
Sadaf AslamIcahn School of Medicine at Mount Sinai New York
Sadaf AslamGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
David A MeekinsCollege of Veterinary Medicine, Kansas State University
Chester McDowellCollege of Veterinary Medicine, Kansas State University
Velmurugan BalaramanCollege of Veterinary Medicine, Kansas State University
Juergen A RichtCollege of Veterinary Medicine, Kansas State University
Lisa MiorinIcahn School of Medicine at Mount Sinai New York
Lisa MiorinGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
Viviana SimonIcahn School of Medicine at Mount Sinai New York
Viviana SimonGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
Viviana SimonIcahn School of Medicine at Mount Sinai New York
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai New York
Adolfo Garc??a-SastreGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai New York
Adolfo Garc??a-SastreThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York
Michael SchotsaertIcahn School of Medicine at Mount Sinai New York
Michael SchotsaertGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
  • 1 - 28

Datasets